Table 4.
Half-life of C-PCBs in laboratory animals and humans.
PCB congener | Species | Gender | Route of administration | Half-life
|
Reference | |
---|---|---|---|---|---|---|
t1 [days] | t2 [days] | |||||
E1-PCB 911 | Mice | Female | Oral | 1.9 | (Kania-Korwel et al. 2010) | |
E1-PCB 911 | Mice | Female | Oral | 2.7 | (Kania-Korwel et al. 2010) | |
E1-PCB 951 | Mice | Female | Oral | 12.9 | (Kania-Korwel et al. 2010) | |
E1-PCB 951 | Mice | Female | Oral | 6.9 | (Kania-Korwel et al. 2010) | |
PCB 952 | Wister rats | Male | Oral | 1.43 | 163 | (Tanabe S. 1981) |
PCB 95 | Humans | 0.4 years4 | (Agency for Toxic Substances and Disease Registry 2000, Wolff and Schecter 1991) | |||
PCB 95 | Humans | 3 years4 | (Agency for Toxic Substances and Disease Registry 2000, Wolff et al. 1992) | |||
(−)-PCB 1321 | Mice | Female | Oral | 15.8 | (Kania-Korwel et al. 2010) | |
(+)-PCB 1321 | Mice | Female | Oral | 5.1 | (Kania-Korwel et al. 2010) | |
PCB 136 | Mice | Female | Oral with diet | 3.2 (2.1–6.9) | (Mizutani et al. 1980) | |
(−)-PCB 1361 | Mice | Female | Oral | 8.3 | (Kania-Korwel et al. 2010) | |
(+)-PCB 1361 | Mice | Female | Oral | 7.1 | (Kania-Korwel et al. 2010) | |
PCB 1362 | Wister rats | Male | Oral | 2.63 | (Tanabe S. 1981) | |
PCB 136 | Beagles (dog) | Male | i.v. | 0.05 | 3.05 | (Sipes et al. 1982) |
PCB 136 | Sprague-Dawley rats | i.v. | 0.24 | 3.6 | (Matthews and Tuey 1980) | |
PCB 136 | Sprague- Dawley rats | Male | i.v. | 0.44 | (Birnbaum 1983) | |
PCB 136 | Cynomolgus monkey | Male | i.v. | 0.16 | 4.57 | (Sipes et al. 1982) |
(−)-PCB 1491 | Mice | Female | Oral | 11.7 | (Kania-Korwel et al. 2010) | |
(+)-PCB 1491 | Mice | Female | Oral | 7.5 | (Kania-Korwel et al. 2010) | |
(−)-PCB 1741 | Mice | Female | Oral | 11.2 | (Kania-Korwel et al. 2010) | |
(+)-PCB 1741 | Mice | Female | Oral | 11.4 | (Kania-Korwel et al. 2010) | |
(−)-PCB 1761 | Mice | Female | Oral | 0.54 | (Kania-Korwel et al. 2010) | |
(+)-PCB 1761 | Mice | Female | Oral | 1.2 | (Kania-Korwel et al. 2010) | |
PCB 1762 | Wister rats | Male | Oral | 3.13 | >903 | (Tanabe S. 1981) |
PCB 1831 | Mice | Female | Oral | 6.9 | (Kania-Korwel et al. 2010) | |
PCB 1832 | Wister rats | Male | Oral | 9.33,5 | >903,5 | (Tanabe S. 1981) |
PCB 1836 | Rhesus monkey (Macaca mulatta) | Female | Oral | 0.63 years (0.33–1.00 years) | (Mes et al. 1995) | |
PCB 183 | Humans | 0.13 years7 | (Agency for Toxic Substances and Disease Registry 2000, Luotamo et al. 1991b) | |||
PCB 183 | Humans | 7.9 years8 | (Agency for Toxic Substances and Disease Registry 2000, Wolff et al. 1992) |
Female C57Bl/6 mice received 50 mg/kg body weight of a PCB mixture containing racemic PCB 91 (6.1% by weight), PCB 95 (24.5% by weight), PCB 132 (12.7% by weight), PCB 136 (4.7% by weight), PCB 149 (30.5% by weight), PCB 174 (13.4% by weight), PCB 176 (1.6% by weight) and PCB 183 (6.5% by weight) in corn oil (5.0 mg PCB/ml corn oil) by oral gavage (Kania-Korwel et al. 2010).
A equivalent mixture of Kanechlor-300, -400, -500 and -600 (3 mg in 1 mL corn oil) was orally administered each day for 5 days (Tanabe S. 1981);
half-life of the total PCB content in the animals;
co-eluting PCBs 95, 56 and 60;
co-eluting PCBs 174 and 183;
Aroclor 1254 was administered daily for six years, followed by a deplete period of three years. For additional experimental details see (Mes et al. 1995);
adipose tissue;
co-eluting PCBs 128 and 183; E1 = first eluting PCB atropisomer; E2 = second eluting PCB atropisomer.